Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:29 PM
Ignite Modification Date:
2025-12-24 @ 5:29 PM
NCT ID:
NCT04468568
Eligibility Criteria:
Inclusion Criteria:
* Pregnant women over 18 years
* Single fetus pregnancy
* Fetus with myelomeningocele
* Gestational age from 19 to 26
* Fetus with normal karyotype
Exclusion Criteria:
* Multiple pregnancy
* Fetal abnormality not related to myelomeningocele
* Kyphosis greater than or equal to 30 degrees
* Placenta previa
* Maternal disease that increases the risk of pregnancy (insulin-dependent DM, hypertension poorly controlled)
* History of incompetent cervix
* Carrier of HIV, hepatitis B or hepatitis C
* Maternal-fetal isoimmunization
* Uterine Alteration
* Obesity (IMC greater than 30)
Healthy Volunteers:
True
Sex:
FEMALE
Minimum Age:
18 Years
Maximum Age:
40 Years
Study:
NCT04468568
Study Brief:
Protocol Section:
NCT04468568